Overview
Use this article to understand the eligibility requirements, accepted documentation, and submission process for requesting a higher dose of Wegovy® or Mounjaro® when transferring treatment from a previous healthcare provider to MedExpress.
Requesting a Higher Dose of Wegovy® or Mounjaro®
You may be eligible to request a higher (step-up or maintenance) dose of Wegovy® or Mounjaro® if you have previously used Wegovy® or Mounjaro® through a different UK healthcare provider.
Before MedExpress can supply a dose higher than the starting strength (0.25 mg for Wegovy® or 2.5 mg for Mounjaro®), recent treatment history must be confirmed to ensure continuation is safe and clinically appropriate.
When a Higher Dose May Be Considered
A higher dose of Wegovy® or Mounjaro® may be considered if:
You have previously used the same GLP-1 medication (Wegovy® or Mounjaro®) with another registered UK healthcare provider.
Your previous healthcare provider is located within the United Kingdom (MedExpress cannot accept Previous Use Evidence from non-UK providers or other countries).
Your most recent treatment with Wegovy® or Mounjaro® occurred within the last 6 months.
Important: If valid UK Previous Use Evidence (PUE) is not provided, you will be required to restart treatment at the initial starting dose (0.25 mg for Wegovy® or 2.5 mg for Mounjaro®) in line with clinical safety guidelines. Alternatively, if valid UK documentation cannot be provided, you may choose to cancel your MedExpress order and receive a full refund.
Accepted Evidence of Previous Treatment (PUE)
To allow safe and informed prescribing decisions, clear documentation of your recent UK treatment must be provided. Accepted forms of UK Previous Use Evidence (PUE) include:
A copy of your previous official UK prescription for Wegovy® or Mounjaro®.
The official UK dispensing label found on your original Wegovy® or Mounjaro® packaging.
A formal receipt or dispatch confirmation from your previous UK healthcare provider.
Note: Verbal confirmations, word-of-mouth accounts, or written statements without supporting official documentation cannot be accepted as valid PUE.
Requirements for Your Documentation
When providing Previous Use Evidence (PUE), ensure the following details are clearly visible on the document:
Your full name or email address: Confirms the medication was prescribed specifically for you (these details must match your MedExpress account name and email address).
Medication name and dosage: Confirms the exact medication (Wegovy® or Mounjaro®) and exact dose strength previously prescribed.
Prescription or dispatch date: Confirms the document is dated within the last 6 months to ensure treatment gap limits are not exceeded.
UK Provider Details: Confirms the documentation originates from a recognized healthcare provider based within the United Kingdom.
How to Submit Your Evidence
Once your order is placed, you will be notified by email if documentation is required.
For Previous Use Evidence (PUE): Note that the general MedExpress upload link cannot be used for PUE documentation. To submit PUE, log in to your MedExpress account, send the documentation via email, or contact MedExpress via live chat on the MedExpress website.
For other verification requests (such as ID and Weight Verification): Submit these via the secure upload link provided in your request email, through live chat, by email, or by logging into your MedExpress account.
Review Process: Once submitted, documentation will be reviewed. Supply of the requested higher dose depends on approval. If evidence is insufficient or from outside the UK, the dose will be limited to the lowest starting dose (0.25 mg for Wegovy® or 2.5 mg for Mounjaro®).
Need Further Support?
If you still need help after reviewing the information above, additional assistance is available.